These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 18057701

  • 21. In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative.
    Draghi DC, Benton BM, Krause KM, Thornsberry C, Pillar C, Sahm DF.
    J Antimicrob Chemother; 2008 Jul; 62(1):116-21. PubMed ID: 18424792
    [Abstract] [Full Text] [Related]

  • 22. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates].
    Hoşgör Limoncu M, Ermertcan S, Taşli H, Kurutepe S.
    Mikrobiyol Bul; 2007 Oct; 41(4):511-6. PubMed ID: 18173069
    [Abstract] [Full Text] [Related]

  • 23. Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1997 Aug 22; 46(33):765-6. PubMed ID: 9272582
    [Abstract] [Full Text] [Related]

  • 24. Update on the telavancin activity tested against European staphylococcal clinical isolates (2009-2010).
    Mendes RE, Sader HS, Farrell DJ, Jones RN.
    Diagn Microbiol Infect Dis; 2011 Sep 22; 71(1):93-7. PubMed ID: 21851873
    [Abstract] [Full Text] [Related]

  • 25. Efficacy of telavancin (TD-6424), a rapidly bactericidal lipoglycopeptide with multiple mechanisms of action, in a murine model of pneumonia induced by methicillin-resistant Staphylococcus aureus.
    Reyes N, Skinner R, Kaniga K, Krause KM, Shelton J, Obedencio GP, Gough A, Conner M, Hegde SS.
    Antimicrob Agents Chemother; 2005 Oct 22; 49(10):4344-6. PubMed ID: 16189117
    [Abstract] [Full Text] [Related]

  • 26. In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates.
    Kotlus BS, Wymbs RA, Vellozzi EM, Udell IJ.
    Am J Ophthalmol; 2006 Nov 22; 142(5):726-9. PubMed ID: 17056356
    [Abstract] [Full Text] [Related]

  • 27. In vitro activities of 28 antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) from a clinical setting in Malaysia.
    Neela V, Sasikumar M, Ghaznavi GR, Zamberi S, Mariana S.
    Southeast Asian J Trop Med Public Health; 2008 Sep 22; 39(5):885-92. PubMed ID: 19058585
    [Abstract] [Full Text] [Related]

  • 28. In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
    Jansen WT, Verel A, Verhoef J, Milatovic D.
    Antimicrob Agents Chemother; 2007 Sep 22; 51(9):3420-4. PubMed ID: 17606689
    [Abstract] [Full Text] [Related]

  • 29. New bisanthraquinone antibiotics and semi-synthetic derivatives with potent activity against clinical Staphylococcus aureus and Enterococcus faecium isolates.
    Socha AM, LaPlante KL, Rowley DC.
    Bioorg Med Chem; 2006 Dec 15; 14(24):8446-54. PubMed ID: 16979896
    [Abstract] [Full Text] [Related]

  • 30. In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients.
    Rolston K, Wang W, Nesher L, Coyle E, Shelburne S, Prince RA.
    J Antibiot (Tokyo); 2014 Jul 15; 67(7):505-9. PubMed ID: 24824818
    [Abstract] [Full Text] [Related]

  • 31. Key considerations in the treatment of complicated staphylococcal infections.
    Jones RN.
    Clin Microbiol Infect; 2008 Mar 15; 14 Suppl 2():3-9. PubMed ID: 18226084
    [Abstract] [Full Text] [Related]

  • 32. Efficacy of telavancin against glycopeptide-intermediate Staphylococcus aureus in the neutropenic mouse bacteraemia model.
    Hegde SS, Difuntorum S, Skinner R, Trumbull J, Krause KM.
    J Antimicrob Chemother; 2009 Apr 15; 63(4):763-6. PubMed ID: 19155225
    [Abstract] [Full Text] [Related]

  • 33. [Mupirocin resistance in methicillin-resistant Staphylococcus aureus strains isolated from wound infections].
    Dolapçi I, Karahan ZC, Tekeli A, Koyuncu E, Azap A, Adaleti R.
    Mikrobiyol Bul; 2007 Jul 15; 41(3):435-40. PubMed ID: 17933255
    [Abstract] [Full Text] [Related]

  • 34. Telavancin in vitro activity against a collection of methicillin-resistant Staphylococcus aureus isolates, including resistant subsets, from the United States.
    Mendes RE, Sader HS, Flamm RK, Farrell DJ, Jones RN.
    Antimicrob Agents Chemother; 2015 Mar 15; 59(3):1811-4. PubMed ID: 25561335
    [Abstract] [Full Text] [Related]

  • 35. Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage.
    Alós JI, García-Cañas A, García-Hierro P, Rodríguez-Salvanés F.
    J Antimicrob Chemother; 2008 Oct 15; 62(4):773-5. PubMed ID: 18552338
    [Abstract] [Full Text] [Related]

  • 36. In vitro activity of daptomycin against multidrug-resistant Staphylococcus aureus and S. aureus with known virulence factors, including community-acquired methicillin-resistant isolates.
    Anastasiou DM, Morgan M, Ruane PJ, Steenbergen JN, Katz BD, Alder JD, Thorne GM.
    Diagn Microbiol Infect Dis; 2008 Jul 15; 61(3):339-42. PubMed ID: 18304772
    [Abstract] [Full Text] [Related]

  • 37. In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studies.
    Krause KM, Barriere SL, Kitt MM, Benton BM.
    Diagn Microbiol Infect Dis; 2010 Oct 15; 68(2):181-5. PubMed ID: 20846593
    [Abstract] [Full Text] [Related]

  • 38. Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007).
    Biedenbach DJ, Jones RN.
    Diagn Microbiol Infect Dis; 2009 Jun 15; 64(2):177-84. PubMed ID: 19249179
    [Abstract] [Full Text] [Related]

  • 39. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Appelbaum PC.
    Int J Antimicrob Agents; 2007 Nov 15; 30(5):398-408. PubMed ID: 17888634
    [Abstract] [Full Text] [Related]

  • 40. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C, Caillon J, Le Mabecque V, Miègeville AF, Hamel A, Bugnon D, Ge JY, Potel G.
    Antimicrob Agents Chemother; 2007 Sep 15; 51(9):3397-400. PubMed ID: 17591849
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.